Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis

M Gambella; P Omede; S Spada; VE Muccio; M Gilestro; E Saraci; S Grammatico; A Larocca; C Conticello; A Bernardini; B Gamberi; R Troia; AM Liberati; M Offidani; A Rocci; A Palumbo; M Cavo; Pieter Sonneveld; M Boccadoro; S Oliva

doi:10.1002/cncr.31854

Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis

M Gambella, P Omede, S Spada, VE Muccio, M Gilestro, E Saraci, S Grammatico, A Larocca, C Conticello, A Bernardini, B Gamberi, R Troia, AM Liberati, M Offidani, A Rocci, A Palumbo, M Cavo, Pieter Sonneveld, M Boccadoro, S Oliva

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

23 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	750-760
Number of pages	11
Journal	Cancer
Volume	125
Issue number	5
DOIs	https://doi.org/10.1002/cncr.31854
Publication status	Published - 2019

Access to Document

10.1002/cncr.31854

http://hdl.handle.net/1765/113395

Cite this

Gambella, M., Omede, P., Spada, S., Muccio, VE., Gilestro, M., Saraci, E., Grammatico, S., Larocca, A., Conticello, C., Bernardini, A., Gamberi, B., Troia, R., Liberati, AM., Offidani, M., Rocci, A., Palumbo, A., Cavo, M., Sonneveld, P., Boccadoro, M., & Oliva, S. (2019). Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis. Cancer, 125(5), 750-760. https://doi.org/10.1002/cncr.31854

Gambella, M ; Omede, P ; Spada, S ; Muccio, VE ; Gilestro, M ; Saraci, E ; Grammatico, S ; Larocca, A ; Conticello, C ; Bernardini, A ; Gamberi, B ; Troia, R ; Liberati, AM ; Offidani, M ; Rocci, A ; Palumbo, A ; Cavo, M ; Sonneveld, Pieter ; Boccadoro, M ; Oliva, S. / Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis. In: Cancer. 2019 ; Vol. 125, No. 5. pp. 750-760.

@article{00f1b74fa9284a5493080dce0c425bf4,

title = "Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis",

author = "M Gambella and P Omede and S Spada and VE Muccio and M Gilestro and E Saraci and S Grammatico and A Larocca and C Conticello and A Bernardini and B Gamberi and R Troia and AM Liberati and M Offidani and A Rocci and A Palumbo and M Cavo and Pieter Sonneveld and M Boccadoro and S Oliva",

year = "2019",

doi = "10.1002/cncr.31854",

language = "Undefined/Unknown",

volume = "125",

pages = "750--760",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley & Sons Inc.",

number = "5",

}

Gambella, M, Omede, P, Spada, S, Muccio, VE, Gilestro, M, Saraci, E, Grammatico, S, Larocca, A, Conticello, C, Bernardini, A, Gamberi, B, Troia, R, Liberati, AM, Offidani, M, Rocci, A, Palumbo, A, Cavo, M, Sonneveld, P, Boccadoro, M & Oliva, S 2019, 'Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis', Cancer, vol. 125, no. 5, pp. 750-760. https://doi.org/10.1002/cncr.31854

Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis. / Gambella, M; Omede, P; Spada, S; Muccio, VE; Gilestro, M; Saraci, E; Grammatico, S; Larocca, A; Conticello, C; Bernardini, A; Gamberi, B; Troia, R; Liberati, AM; Offidani, M; Rocci, A; Palumbo, A; Cavo, M; Sonneveld, Pieter; Boccadoro, M; Oliva, S.

In: Cancer, Vol. 125, No. 5, 2019, p. 750-760.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis

AU - Gambella, M

AU - Omede, P

AU - Spada, S

AU - Muccio, VE

AU - Gilestro, M

AU - Saraci, E

AU - Grammatico, S

AU - Larocca, A

AU - Conticello, C

AU - Bernardini, A

AU - Gamberi, B

AU - Troia, R

AU - Liberati, AM

AU - Offidani, M

AU - Rocci, A

AU - Palumbo, A

AU - Cavo, M

AU - Sonneveld, Pieter

AU - Boccadoro, M

AU - Oliva, S

PY - 2019

Y1 - 2019

U2 - 10.1002/cncr.31854

DO - 10.1002/cncr.31854

M3 - Article

VL - 125

SP - 750

EP - 760

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 5

ER -